GSEA revealed significant enrichment in the non-alcoholic fatty liver disease, staphylococcus aureus infection, systemic lupus erythematosus, asthma, intestinal immune network for IgA production, and apoptosis (Figure 4). The gene discussed is CD79A; the disease is systemic lupus erythematosus.